D

DelRicht Research | Springer Wellness and Restorative Health

Research site

(Unclaimed)

Location

17 Executive Park Suite 480, Atlanta, Georgia, United States of America

Site insights

Top conditions

Top treatments

Clascoterone

Galcanezumab

Azetukalner

Parent organization

This site is a part of DelRicht Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...

Enrolling

Major Depressive Disorder

Drug: Azetukalner

Drug: Placebo

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age wi...

Enrolling

SARS-CoV-2

Biological: mRNA-1283

Biological: mRNA-1273

A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza (ANCHOR)

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to pla...

Active, not recruiting

Influenza

Combination Product: CD388 Injection

Combination Product: Placebo

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a...

Enrolling

COVID-19

SARS-COV-2 Infection

Biological: Placebo

Biological: BNT162b2 Vaccine